| Literature DB >> 29154162 |
Zhiyong Cheng1, Louise Zheng2, Fabio A Almeida3.
Abstract
Environmental factors (e.g., malnutrition and physical inactivity) contribute largely to metabolic disorders including obesity, type 2 diabetes, cardiometabolic disease and nonalcoholic fatty liver diseases. The abnormalities in metabolic activity and pathways have been increasingly associated with altered DNA methylation, histone modification and noncoding RNAs, whereas lifestyle interventions targeting diet and physical activity can reverse the epigenetic and metabolic changes. Here we review recent evidence primarily from human studies that links DNA methylation reprogramming to metabolic derangements or improvements, with a focus on cross-tissue (e.g., the liver, skeletal muscle, pancreas, adipose tissue and blood samples) epigenetic markers, mechanistic mediators of the epigenetic reprogramming, and the potential of using epigenetic traits to predict disease risk and intervention response. The challenges in epigenetic studies addressing the mechanisms of metabolic diseases and future directions are also discussed and prospected.Entities:
Keywords: DNA methylation; Epigenetic marker; Intervention; Metabolic disorders; Reprogramming
Mesh:
Substances:
Year: 2017 PMID: 29154162 PMCID: PMC5866737 DOI: 10.1016/j.jnutbio.2017.10.004
Source DB: PubMed Journal: J Nutr Biochem ISSN: 0955-2863 Impact factor: 6.048